SPATS2L and atrial fibrillation: Future studies should employ functional experiments (e.g., gene editing and ex vivo cardiomyocyte models) and animal models to validate SPATS2L's direct effects on cardiac electrophysiology and elucidate its interplay with sodium channel activity, calcium homeostasis, and other pathological processes critical to AF.